Lipotec adds to its successful molecular actives range a novel hexapeptide to treat wrinkles caused by muscle contraction: Inyline™

On the forefront of pre-synaptic strategy, Lipotec sums a new focus on its progress to treat expression wrinkles. Inyline™ acts at post-synaptic stage, before acetylcholine (ACh) released from motor neuron reaches its receptor (AChR).

Inyline™ blocks the agrin binding site in MuSK (Muscle-Specific Kinase), so disrupting  AChR clustering; a requirement for the ACh to trigger the action potential that precedes muscle contraction.

An innovative approach that brings a new peptide to lead the muscle to the relaxation, minimizing expression wrinkles formation.